Kessler Investment Group, LLC Celcuity Inc. Transaction History

Kessler Investment Group, LLC

  • $161 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 21, 2019
SELL
$15.74 - $23.65 $93,275 - $140,149
-5,926 Closed
0 $0
Q2 2019

Jul 23, 2019
SELL
$19.88 - $25.0 $21,689 - $27,275
-1,091 Reduced 15.55%
5,926 $148,000
Q1 2019

Apr 16, 2019
BUY
$18.38 - $24.44 $40,840 - $54,305
2,222 Added 46.34%
7,017 $154,000
Q4 2018

Jan 11, 2019
BUY
$20.87 - $29.05 $100,071 - $139,294
4,795 New
4,795 $115,000

Others Institutions Holding CELC

# of Institutions
82
Shares Held
22.9M
Call Options Held
24.9K
Put Options Held
4K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $253M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Kessler Investment Group, LLC Portfolio

Follow Kessler Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kessler Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email